TRIP4 overexpression in cervical cancer cells and tumor tissues may promote EMT and activate the PI3K/Akt and MAPK/ERK signaling pathways, enhancing radiation resistance in cervical cancer [71]. This evidence concerns the gene AKT1 and cervical carcinoma.